Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Lessons from treatment resistant hyperlipidaemia
Elizabeth Parsons1, Pankaj Gupta1, Prashanth Patel1
1University Hospitals of Leicester NHS Trust, Department of Chemical Pathology and Metabolic Medicine , Level 4, Sandringham Building , Leicester Royal Infirmary , UK.
Abstract:
A 68-year-old woman was referred to Lipid Clinic with sudden deterioration of previously well-controlled primary hyperlipidaemia. Investigations revealed nephrotic range proteinuria, leading to urgent renal biopsy and a diagnosis of amyloidosis. Chemotherapy was successful in stabilising renal function, reducing proteinuria and eliminating serum paraprotein. The resistant hyperlipidaemia subsequently resolved. Whilst hyperlipidaemia is pathognomonic of nephrotic syndrome, it is rarely the first characteristic identified by clinicians, often preceded by the identification of oedema or proteinuria. This case is an unusual example of a nephrotic syndrome presenting to Lipid Clinic as a resistant primary hyperlipidaemia, and highlights the importance of considering superimposed secondary causes of hyperlipidaemia in treatment resistant cases.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Coronary Artery Disease IV: Preventive Measures
Angina IV: Management
Cardiomyopathy V: Interprofessional Care

